HealthLeap, an AI platform that helps clinicians prioritize and care for patients, today announced the addition of new executive leadership as the company enters its next phase of rapid growth in 2026 ...
Years after the split, the payment helped turn Melinda French Gates’ foundation into one of the largest private ...
Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...
Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at ...
Zacks.com on MSN
CRISPR Therapeutics (CRSP) Is Considered a Good Investment by Brokers: Is That True?
CRISPR Therapeutics (CRSP) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast ...
A new analysis of railroad accident data reveals a recurring cycle of industry opposition and federal inaction to attempts to ...
Community colleges are expanding child care access and affordability in three primary ways: providing on-campus child care ...
Zacks Investment Research on MSN
Owlet stock up more than 82% in the past 6 months: Still worth buying?
Owlet, Inc. OWLT has delivered one of the strongest stock performances in the small-cap consumer health space, with shares up ...
SAN JOSE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, ...
EverForward has officially launched as a new proprietary trading firm, supported by a strategic alliance with an established ...
Founded in Leeds, UK in 2005 by Jonathan Million, Blue Yonder has grown into a trusted partner to a diversified, global client base spanning the U.K., United States, Latin America, Asia, and ...
Health Enterprise Partners ("HEP"), a leading healthcare-focused private equity firm, today announced that Roland Lyon has ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果